BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 25913730)

  • 1. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
    Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
    Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
    So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
    Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.
    Liu LS; Liang J; Li JH; Liu X; Jiang L; Long JX; Jiang YM; Wei ZX
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1327-1338. PubMed ID: 27645473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoring system is an effective tool for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a case-control study.
    Cai YF; Wang QX; Ni CJ; Zhang XJ; Chen ED; Dong SY; Zheng HM; Zhang XH; Li Q
    World J Surg Oncol; 2016 Feb; 14(1):45. PubMed ID: 26911241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
    Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
    World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
    So YK; Seo MY; Son YI
    Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Necessity of central lymph node dissection in management of papillary thyroid microcarcinoma].
    Xu X; Jiang B; Han L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):362-5. PubMed ID: 24961119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent Risk Factors Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
    Yu X; Song X; Sun W; Zhao S; Zhao J; Wang YG
    Horm Metab Res; 2017 Mar; 49(3):201-207. PubMed ID: 28351086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.
    Wang Y; Guan Q; Xiang J
    Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of logistic regression and artificial neural networks in predicting central lymph node metastases in papillary thyroid microcarcinoma.
    Ozden S; Er S; Saylam B; Yildiz BD; Senol K; Tez M
    Ann Ital Chir; 2018; 89():193-198. PubMed ID: 30588918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
    Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
    World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma.
    Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ
    Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
    Qiu P; Guo Q; Pan K; Lin J
    BMC Cancer; 2024 Feb; 24(1):235. PubMed ID: 38378515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
    Zhang Q; Wang Z; Meng X; Duh QY; Chen G
    Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
    Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
    Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
    Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
    J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.